Federal Register Notice: FDA is withdrawing approval of 27 NDAs and 58 ANDAs from multiple applicants. The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. To view this notice, click here.
